Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

July 31, 2008

Conditions
Chronic Plaque Psoriasis
Interventions
DRUG

E6201 0.005%

DRUG

E6201 0.01%

DRUG

E6201 0.03%

DRUG

Placebo

Trial Locations (12)

Unknown

Hot Springs

San Diego

Boise

Champaign

Clinton Township

Fridley

Omaha

Carlstadt

Portland

Austin

College Station

Lynchburg

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00539929 - Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis | Biotech Hunter | Biotech Hunter